Dyne Therapeutics (DYN.US) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Nov13

Oppenheimer Downgrades Dyne Therapeutics Target Price

16:36

Nov12

Oppenheimer analyst maintains hold rating on Dyne Therapeutics

13:02

Nov6

Analysts Maintain Buy Rating for Dyne Therapeutics, Price Targets Set at $36 and $48

14:22

Dyne Therapeutics released FY2025 9 Months Earnings on November 5, 2025 (EST), with actual revenue of USD 0 and actual EPS of USD -2.7849

04:00

Dyne Therapeutics released FY2025 Q3 earnings on November 5 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.7618 (forecast USD -0.8383)

04:00

Nov5

Dyne Therapeutics Reports Positive Clinical Data and Future Plans for DMD and DM1 Therapies

21:16

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -108.04 M, EPS -0.7618

Jul28

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -110.86 M, EPS -0.9735

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -115.36 M, EPS -1.0495

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change